Research progress on correlation between hyperphosphatemia and calciphylaxis in patients with chronic kidney disease
10.3969/j.issn.1006-2483.2025.02.027
- VernacularTitle:慢性肾脏疾病患者高磷血症与钙化防御的相关性研究进展
- Author:
LI YANG
1
;
Li ZHOU
1
;
Xue GAO
1
Author Information
1. Hemodialysis Room ,Department of Nephrology ,West China Hospital/West China Nursing College , Sichuan University , Chengdu , Sichuan 610041, China
- Publication Type:Journal Article
- Keywords:
Chronic kidney disease;
Hyperphosphatemia;
Calciphylaxis;
Pathogenesis
- From:
Journal of Public Health and Preventive Medicine
2025;36(2):121-125
- CountryChina
- Language:Chinese
-
Abstract:
Hyperphosphatemia is a common complication in patients with advanced chronic kidney disease, which is an important factor causing secondary hyperparathyroidism, calcium-phosphorus deposition changes, vitamin D metabolism disorders and renal osteopathy. Calciphylaxis is a rare and highly fatal disease in clinical practice, which is generally believed to be related to abnormal calcium-phosphorus metabolism. Based on the results of previous studies, this paper summarizes the relationship between calciphylaxis and hyperphosphatemia, its occurrence mechanism, and prevention and treatment methods, in order to improve the awareness and attention of this disease.
